Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ENGN · against 119 other Healthcare companies of similar size
Ranked #14 of 120 · scores higher than 89% of peers · safety percentile 92
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)18 peers with a safety percentile of 90–100, including ENGN · Click a bar to see the companies
Mainly thanks to its current ratio, which is stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ENGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 105 reported | 0.14× | 0.21× | 57% | 33% | |
| BetaLower is better · 114 reported | -0.27 | 0.67 | 98% | 33% | |
| Current ratioHigher is better · 120 reported | 10.21× | 3.04× | 83% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 186M USD | 100 | 52 | |
| 2 | 165M USD | 99 | 50 | |
| 3 | 284M AUD (≈$188M) | 98 | 36 | |
| 4 | 8.4B JPY (≈$57M) | 98 | ||
| 5 | 213M USD | 98 | ||
| 10 | 216M USD | 95 | 44 | |
| 11 | 215M USD | 94 | 34 | |
| 12 | 83.4B KRW (≈$60M) | 93 | 36 | |
| 13 | 184M USD | 92 | 33 | |
| 14 | 109M USD | 92 | 47 | |
| 15 | 149M USD | 91 | ||
| 16 | 205M USD | 91 | 36 | |
| 17 | 83.8B KRW (≈$60M) | 91 | 54 | |
| 18 | 3.4B TWD (≈$106M) | 90 | 36 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score